Indeed, it has been reported that decreases in XDH activity levels are associated with poor prognoses for cancers, including breast cancer [23], gastric cancer [24], ovarian cancer [25], non-small-cell lung cancer [26] and colorectal cancer [27]. This evidence concerns the gene XDH and gastric cancer.